Prospective, Randomized, Observer-blind, Parallel-group, Multi-center Trial to Assess Efficacy and Safety of Two Different Dilutions of incobotulinumtoxinA (Xeomin) in Patients With Upper Limb Spasticity

Trial Profile

Prospective, Randomized, Observer-blind, Parallel-group, Multi-center Trial to Assess Efficacy and Safety of Two Different Dilutions of incobotulinumtoxinA (Xeomin) in Patients With Upper Limb Spasticity

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Aug 2016

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Muscle hypertonia
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Aug 2016 Results (n=572) of this and other two phase 3 trials published in the Drugs (2016).
    • 21 Nov 2011 New trial record
    • 17 Nov 2011 Results will be presented at the 72nd Annual Assembly of the American Academy of Physical Medicine and Rehabilitation, according to a Merz Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top